Contact
Please use this form to send email to PR contact of this press release:
ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP
TO: